Pusic I, Miklos D, Cutler C, et al. Ibrutinib for chronic graft-versus-host disease after failure of frontline corticosteroids: results of a multicenter open-label phase 2-study. EHA 2017, S492.
Klinische uitkomsten van DOAC versus warfarine bij langdurige VTE-behandeling
nov 2023 | Benigne hematologie